A Delhi-based medtech company just delivered explosive 10x growth, but the cash story isn’t as strong as the profits suggest. Big numbers, rising margins, and one major red flag investors can’t ignore.
A Delhi-based medtech company just delivered explosive 10x growth, but the cash story isn’t as strong as the profits suggest. Big numbers, rising margins, and one major red flag investors can’t ignore.